ResNullius said:"Drug stocks have been a very profitable area for many years. Anyone have any wisdom on whether the next couple of years look to be as bright as the last several years. Buy and hold is my philosophy, but I have been wondering about it's applicability to drug stocks, given the present state of politics and economics."I reply: While drug stocks in general may be good, individual drug companies may be a rolly coaster. I rode Lilly (LLY) up to $105 about 18 months ago, then down to mid 50's on patent expiration fears for Prozac, then up to $108 on some new discovery, then down 30 pts on the news that the genereic form of Prozac may come sooner. It is now in the low 80's. In general, the gov appears to want to rein in the prescription costs which, if and when enacted, will bring lower profits to these companies. So, in summary, IMHO, I would not look to drugs as a sure-fire winner in the short term (2-3 years).
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar<